We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S.-India IP Working Group Bodes Well for Addressing Branded Drugmakers Concerns
U.S.-India IP Working Group Bodes Well for Addressing Branded Drugmakers Concerns
Branded drugmakers have expressed guarded optimism at the announcement of high-level intellectual property talks between the U.S. and India, hoping the discussions will resolve long-standing worries over a lack of effective patent protection by the Indian government.